Sector Focus Bourne Partners operates at the intersection of investment banking and strategic capital within pharma, pharma services, healthcare services, and consumer health, presenting opportunities to cross-sell advisory services, portfolio company financing, and strategic partnerships to healthcare clients and PE firms seeking healthcare sector exposure.

Strategic Capital Synergy Their dual-structure model combines traditional investment banking with long term strategic investments, suggesting sales potential in co-investment opportunities, minority/majority equity financing, and bespoke capital solutions for portfolio companies in the life sciences and healthcare spaces.

Notable Partnerships History of collaboration with Cerberus, Carlyle, Emerson Group, Blackstone, and MannKind indicates a strong appetite for alliance-driven deals and international licensing, offering avenues to pitch joint ventures, licensing deals, and cross-border capital solutions.

Global Healthcare Focus With a mission to move capital efficiently through the global healthcare sector and a track record of supporting pharma and related services, opportunities exist to present market expansion strategies, global access programs, and licensing partnerships to growth-stage and mature healthcare entities.

Growth and Scale Signals Revenue range and active expansion through Carlin Consumer Health initiatives suggest clients looking for scalable capital structures, advisory for M&A or equity/debt financing, and strategic exits, making Bourne Partners a candidate for sales of investment banking, restructuring, or capital advisory services.